Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
15.74
-0.02 (-0.13%)
At close: Aug 15, 2025, 4:00 PM
15.49
-0.25 (-1.59%)
After-hours: Aug 15, 2025, 5:14 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Sterigenics | 697.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sterigenics Growth | 5.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion | 173.36M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Growth | -1.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs | 229.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Growth | -3.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | 941.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | 3.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | 158.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | -1.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Sterigenics Capital Expenditures | 131.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sterigenics Capital Expenditures Growth | -36.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Capital Expenditures | 34.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Capital Expenditures Growth | -12.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Capital Expenditures | 12.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Capital Expenditures Growth | 106.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Sterigenics Segment Income | 378.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sterigenics Segment Income Growth | 5.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Segment Income | 101.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nordion Segment Income Growth | -3.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Segment Income | 69.18M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nelson Labs Segment Income Growth | 6.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| United States | 616.68M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 208.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 196.01M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic | 78.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Geographic Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|